Moustafa Abdou: New Horizons in Hematology and Recent Drug Approvals
Moustafa Abdou, Author and Founder of AskHematologist.com, shared a post on LinkedIn:
“New Horizons in Hematology: A Review of Recent Drug Approvals
Recent advances in hematology are rapidly transforming the management of both malignant and non-malignant blood disorders.
From gene therapy and non-factor treatments in hemophilia to targeted therapies such as JAK inhibitors and antibody–drug conjugates in hematologic malignancies, modern therapeutics are increasingly driven by precision medicine and molecular targeting.
Agents such as brentuximab vedotin have redefined lymphoma treatment, while ruxolitinib has significantly improved outcomes in myeloproliferative neoplasms.
In resistant leukemias, novel agents like omacetaxine offer alternative mechanisms to overcome treatment resistance.
Equally important are advances in supportive care.
G-CSF therapies, iron chelation, direct oral anticoagulants, and enzyme replacement therapies have reduced complications and improved quality of life across a wide range of hematologic conditions.
These developments highlight a comprehensive shift toward more effective, personalised, and safer treatment strategies in hematology.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development
-
Oct 20, 2026, 03:13Sumyea Kabir: Pre-Analytical Quality in Phlebotomy – Preventing In Vitro Hemolysis
-
Oct 20, 2026, 02:37M. Sekip Altunkan: Can Anticoagulation Be Safely Stopped After AF Ablation?
-
Oct 20, 2026, 02:26Ahmed Ammar: Managing VT Recurrence Post-Ablation
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation